chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Seizure that left me unable to breath and rushed to ER then placed in a medically induced coma and intebated for 2 days. Cavernous malformation with venous anomaly that experienced a leak or bleed. Intercranial bleed, acute kidney injury, acute respiratory failure, altered mental status, leukocytosis, status epilepticus
5 days after injection started a light headache. 6 days after injection joint pain, in hips and tailbone. feeling fatigue, nausea. with decreased appetite. Night time of day 6 stomach cramps with diarrhea.
Initially had terrible headache, extensive vomiting, extreme  sensitivity to light, sound, smell & touch.   Also vision disturbances for a few days of seeing colored designs moving all over the walls both during the daylight & dark. On 4/25/16, when I woke everything was dark. I asked to turn on lights & was told they were on. That darkness remains to this day. Dr. was my oncologist while hospitalized & still treats me. He said it was the worse reaction he'd ever seen. While in hospital I saw Ophthalmologist.  I continued to see him thru August when he felt he could do no more for me. From discharge thru December 2016, I was unable to drive due to decreased vision. Ophthalmologist seen Nov 2016. After cataract surgery in December, 2016 & also in March, 2017 along with c lens implants & prescription eyeglasses I am able to  drive some, although the darkness prevails. Dr noted optic nerve damage as well as damage to my iris. Prior to hospitalization in March of 2016 I had my routine eye exam & no surgery was indicated at that time.
Pt experienced swelling and pain at injection site, fever for three days. Pt also experienced nausea and vomiting for one day.
Patient stated that she received first dose of Pfizer vaccine in March but needed second dose in order to return to work.  Patient stated that she did not have her vaccine card.  First dose was processed at the and date not readily available.  Patient stated she never received second dose and dose was given on 07/30/2021 to complete the series.  found documentation of patient receiving a shot on 03/04/2021 and on 03/25/2021.  Patient was given a 3rd dose in error and has been advised.  Patient now has documentation of vacinnation.  Patient reports no adverse events from the 3rd dose at this time.
Triggered menieres, it took me a few days to realize what was going on but now recognize it. This has been dormant for about 18 months, except for hearing loss. My right ear has been the problem but since shot left ear has also been hurting and ringing as well
Patient was sitting upright in chair looking down at phone. Had a syncopal episode, fell to floor, had seizure activity that lasted 5-10 secs. Patient awakened on his own, confused. Tried to get off of floor. Asked to stay on right side of floor. Vitals obtained. A/Ox2. Patient diaphoretic, pale, with shivering. Abrasions to right side of forehead and right posterior shoulder. BP 89/56, HR 56, O2 99% at 1257. Patient able to go from sitting to standing position to be sat in chair. Father notified of events. Father wanted patient to stay here at site for one hour. Within 5 mins of sitting in chair, patient became diaphoretic and pale again with focal stare. Per patient, "I can't hear or see you at the moment." EMS activated. BP obtained again, 78/52, HR 63, O2 at 99%. EMS arrived and assessed patient. Decided to take to Hospital. Father called and notified. Father will meet son at emergency dept.
COVID 19 Treatment; COVID 19 Treatment; Interchange of vaccine products; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Oct2022 as dose 5 (booster), single (Lot number: GH9702) at the age of 65 years, in left leg for covid-19 immunisation; BNT162b2 (BNT162B2), on 12Mar2021 as dose 1, single (Lot number: FN6208), in right arm, on 02Apr2021 as dose 2, single (Lot number: FR2734), in left arm and on 03Oct2021 as dose 3 (booster), single (Lot number: FC3S92), in right arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 03Mar2022 as dose 4 (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing). No Known allergies. The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 21Oct2022, outcome "unknown"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 30Dec2022, outcome "not recovered" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of vaccination failure, covid-19. The patient received treatment of COVID-19 from 30Dec2022 to 04Jan2023.
Arm pain, injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever (100.6), swelling, redness, feeling unwell, decreased appetite, diarrhea  TREATMENT: 2 Ibuprofin OUTCOME Feeling better, decreased fever
inflammation of my eye suckers and cheekbones; eyes were swollen shut; severe facial pain; inflammation of my eye suckers and cheekbones; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 1, single (Lot number: EW0158), in left arm for covid-19 immunisation. The patient's relevant medical history included: "COVID-19" (unspecified if ongoing), notes: Patient had COVID-19 prior vaccination. There were no concomitant medications. Past drug history included: Cephlex, reaction(s): "Known allergies: Cephlex", notes: Known allergies: Cephlex. The following information was reported: EYE INFLAMMATION (non-serious), OSTEITIS (non-serious), outcome "recovered" and all described as "inflammation of my eye suckers and cheekbones"; EYE SWELLING (non-serious), outcome "recovered", described as "eyes were swollen shut"; FACIAL PAIN (non-serious), outcome "recovered", described as "severe facial pain".  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Patient after 1st vaccine had events that lasted 2 weeks. Patient had not tested for COVID post vaccination.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201094320 Same patient/drug, different event sep in time;
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Regulatory authority consulted with the regulatory authority and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare facility is working with the regulatory authority on a compliance improvement plan and has been reinstated vaccination privileges.
Patient began itching on the arm where the vaccine was given. Itching later turned to what she described as nerve pain inside and down her arm. Skin eventually broke down and is still broken. She saw her physician as was told it could be a delayed reaction to the flu vaccine. Patient was prescribed Clobetasol ointment and Hydroxyzine HCl tablets. As of 10/31/17 skin is still broken and patient feels like it is much better but she continues to keep it covered with a large Band Aid.
FACIAL PALSY(RIGHT SIDE) DAY AFTER ADMINISTRATION NO OTHER COMPLAINT REFERD BY PT. NO FEVER GENERAL MALAISE OR HEADACHE.EVALUATED BY ENT GIVEN MEDROL PO AND ALSO NEUROLOGIST WHO GAVE PT ACICLOVIR PO.SENT TO PHYSIOLOGIST FOR PHYSICAL THERAPY.CAME TO PEDIATRICIAN WHO ADMINISTRATED VACCINES TO INFORM HER OF SYPMTOMS.GIVEN VITAMIN B COMPLEX,REASSURANCE AND REFERD FOR PHYSICAL  THERAPY.
about 10min p/vax pt exp vomiting, hives, resp wheezing & dyspnea;immed given adrenalin transported to ER 1 block away;DPH given & observed 1hr;
This spontaneous report was received from a healthcare professional who was also a patient's mother and referred to a female patient of an unknown age. The patient had no relevant medical history or drug history. On an unknown date, the patient was vaccinated with the first dose of M-M-R II (dose, frequency, route of administration, lot# and expiration date were not reported). The patient's mother reported that the patient received many unknown vaccines on an unknown date, at the age of 18 months. These vaccines were the normal vaccines that a child of 18 months would receive, but the reported did not have specific names. On an unknown date, after receiving these vaccines the patient experienced a slight mental decline which was displayed in the patient's speech. This slight mental decline did resolve on an unknown date. On 02-SEP-2016 (reported also as 02-SEP-2017) at the age of 2, the patient was vaccinated with the second dose of M-M-R II (dose, frequency, route of administration, lot# and expiration date were not reported). The patient's concomitant medications administered on the same day included diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid and varicella virus vaccine live (oka/merck) (manufacturer unknown). The patient's mother stated that these were all given to "catch her up" so she could get in the "STEP" program. On an unknown date in September 2016, reported as on 3rd or 4th week of September 2016, after receiving these vaccines, the patient experienced a pronounced mental decline that included speech and memory. One of the memory disorder symptoms was that the patient began forgetting colors. On an unknown date, mental deterioration was noticed by the patient's teachers, which led to the patient being admitted to special education (unknown date). The patient continued to attend the special education. The patient's laboratory data was unknown. The outcome of pronounced mental decline that included speech and memory was unknown. The causailty assessment was not reported. Upon internal review, both episodes of mental deterioration were condidered to be medically significant.  Additional information has been requested.
Severe and prolonged injection site pain in left deltoid, affecting range of motion.   Still persists as of 2/2/2021.
We got our shots (flu and COVID-19) a couple of days ago at our local withheld pharmacy. For the  1st time in my memory, I "suffered" some reactions, primarily in my upper left arm; where both shots; This is a spontaneous report received from non-contactable reporter(s) (Physician).  A male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 28Sep2023 as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 28Sep2023 as dose number unknown, single (Batch/Lot number: unknown), in left arm for immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Moderna covid-19 vaccine (Dose number: Unknown, Previous COVID shots were from Moderna.), for COVID-19 Immunization. The following information was reported: VACCINATION SITE REACTION (non-serious) with onset 28Sep2023, outcome "unknown", described as "We got our shots (flu and COVID-19) a couple of days ago at our local withheld pharmacy. For the  1st time in my memory, I "suffered" some reactions, primarily in my upper left arm; where both shots". Additional information: Patient got  shots (flu and COVID-19) a couple of days ago at local pharmacy. For the 1st time in  memory, patient "suffered" some reactions, primarily in upper left arm; where both shots were administered. Maybe patient can blame Pfizer. Previous COVID shots were from Moderna."  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Two days after first vaccine, patient states that she experienced lymphadenopathy of left armpit. Resolved without treatment after a week.
Very itchy skin subsided briefly then purple rash on right thumb which quickly subsided. Face became very reddened-stopped after 2 days.Two days later hives became generalized. Symptoms present at time of evaluation with Agency Health who did not believe event connected to flu shot.  Shot received at Pharmacy. Prescribed Claritin 10 mg po Pepcid 20 mg po and Xygal( not taken) and Hydroxizine 25 mg po to
Developed site tenderness, swelling, redness and warmth that started the day after the immunization was given, the symptoms gradually worsened, patient called the office back to report symptoms on 11/5/16 and was scheduled an appointment to be seen. Patient ordered AUGMENTIN antibiotic for treatment of reaction.
large local rxn, swelling, tenderness of 5-7inches lt deltoid;als had onset chills, sore throat, fatigue on evening of vax & urticarial rash  1wk p/ax;latter sx consistent w/viral infect;local irritation & flu sx lasted 3 days;
red rash at injection site,  pain at injection sight, fever of 100.8 degrees, chills, restlessness, agitation.
Patient said she became very hot and unable to sleep until roughly 4am. She called the pharmacy at 8am and said she was feeling better and asked if she could take advil due to headache from lack of sleep.
PATIENT EXPERIENCED THE INABILITY TO WALK OR STAND APPROXIMATELY 24 HOURS AFTER THE VACCINE HAD BEEN GIVEN. THE NEXT DAY THEIR CONDITION IMPROVED AND PATIENT WAS ABLE TO STAND AND WALK AGAIN.
A pain first occurred in the hips/buttocks and over the following 2-3 days spread up to my shoulders. Over the course of about two weeks the intensity of the pain became unbearable and I went to my primary physician. After some blood tests, he diagnosed Polymyalgia Rheumatica and prescribed 20mg of Prednisone, which did nothing to suppress the pain. I was referred to a rheumatologist who increased the Prednisone treatment to 40mg. This suppressed the pain by about 80%. After about 1-2 weeks at that dosage, I started a reduced dosage to wean me from the Prednisone and at the same time was prescribed a progressively increased amount of Gabapentin over about a three week period. Over that period, the pain started to become more intense. I'm currently in intense pain and awaiting a doctor's visit.
Information regarding PREVAR was received from a healthcare professional regarding a 6-month-old patient who experienced excessive site redness. At 6 months of age, the patient received a dose on an unspecified date. Relevant medical history was not provided. Product was administered on an unspecified date. Dose regimen was 1 dose 1 time per day (intramuscular). Concomitant medications were not reported. The patient experienced excessive site redness (injection site erythema) on 25-Nov-2007. Patient was treated with BENADRYL and an antibiotic, but has not yet recovered. No further information was provided.
Patient has an allergy to influenza vaccine. Consulted with pulmonologist and advised to get COVID vaccine. She received first dose on 2/23/2021 with no adverse event or side effects. Second dose given on 3/23/2021. Began having raspy voice, hoarseness, "felt lump in throat" approximately 15 minutes after vaccination. BP 146/96. Lungs clear. No difficulty breathing or difficulty swallowing during monitoring period but taken to ED for evaluation due to history of allergic reaction to influenza vaccine.  Patient was admitted to ICU.
Vertigo/spinning; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the right arm on 03May2021 at 09:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included heart failure and kidney failure and chronic obstructive pulmonary disease (COPD). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included warfarin (MANUFACTURER UNKNOWN), allopurinol (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and "fu"; all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 08Apr2021 at 09:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. On 05May2021 at 09:30, the patient experienced vertigo, spinning followed by vomiting which happened 4 times in a 24 hour period. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events vertigo/spinning and vomiting were resolved with sequelae on an unknown date in May2021.  No follow-up attempts are needed. No further information is expected.
This spontaneous report was received from a physician refers to a 28 year old male patient. The patient was vaccinated with a dose of 0.5 ml PNEUMOVAX 23. On an unknown date, the patient experienced high fever of 104 degrees, aches and pain, dizziness and excruciating pain in the armpit area after receiving the vaccination. There were no treatment information reported. The outcome of the events were unknown at the time of this report. This is one of several reports received by the same reporter. Additional information has been requested.
The dose for the Moderna vaccine is 0.5 mL. The patient inadvertently received an extra 0.01 to 0.02 mL. The manufacturer instructed us to contact the patient to inform them that the excess dose could potentially lead to side effects that could be local or systemic. No serious adverse events were experienced by the patient.
Pt reports onset of pain 1 day after vaccination. Pain is in upper left arm radiates to neck / under arm. No erythema, no warmth, no flu chance at injection site. Muscles and skin tender to even light palpation along affected area. Pt also reports spiking temperature to 102 degrees F around midnight frequently. Reports decreased and left UE strength. Exam 4/5 on left no change
50 cent piece size red, hot it hurts to touch. Motrin as directed and warm pack to injection site.
Extreme pain upon injection. Pain in arm has expanded to entire arm with little relief using ice/heat/OTC pain meds. Attempted to see physician but was told to report it to the administration site and for them to suggest treatment. Pain persisting for almost 5 weeks and attempting to set up appointment with orthopedic physician.
I recieved the flu mist vaccination on 10/17 at 9:30 AM.  Within a few hours, I developed a headache and nasal congestion.  Over the next two days, these symptoms continued and worsened.  By the evening of 10/19, I was feeling terrible.  Throughout the night, I progressed to having extreme chills, fever, sweats, body aches, a pounding headache and nasal congestion/running nose.  Today is 10/20, and these synptoms are still present. I feel terrible and very ill.
Initial report received on 21 November 2007 from a health care professional. A 34-year-old female patient had received a left deltoid injection of FLUZONE, lot number U2486AA, and a right deltoid injection of PNEUMOVAX, manufacturer Merck, lot number 1417U; on 20 November 2007. Later that evening, the patient experienced left arm pain extending into the left axilla and left neck and a fever of 101.0 degrees Fahrenheit. At the time of this report, the patient had not recovered.
left arm started to hurt 1 week after injection. Continues to complain of pain when lifting arm.
Patient stated that within 30 minutes she became dizzy/lightheaded.  Her lips started burning like they were on fire and there was "white stuff" oozing from her eyes.
"2 days of my arm feeling hot and like it had taken a few hard slugs" "upper arm  still has a reddish hive splotches and is somewhat swollen".
swollen and sore armpit / Left armpit, axillary area - swelling and tenderness started; swollen and sore armpit / Left armpit, axillary area - swelling and tenderness started; Left armpit, axillary area - swelling and tenderness started; injection site soreness; headache; muscle aches; This case was reported by a consumer and described the occurrence of injection site pain in a 55-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 4th December 2020, the patient received Shingrix (intramuscular). On 4th December 2020, less than a day after receiving Shingrix, the patient experienced injection site pain and headache. On 5th December 2020, the patient experienced swelling arm, axillary pain, muscle pain and tenderness. On an unknown date, the outcome of the injection site pain, swelling arm, axillary pain and tenderness were recovering/resolving and the outcome of the headache and muscle pain were recovered/resolved.   It was unknown if the reporter considered the injection site pain, swelling arm, axillary pain, headache, muscle pain and tenderness to be related to Shingrix.  Additional details were reported as follows: The patient received 1st dose of Shingrix and experienced headache, muscle aches, injection site soreness and left armpit, axillary area swelling and tenderness also swollen and sore armpit. On 8th December 2020, headache and muscle aches were recovered No other information was provided. The reporter consented to follow up.
Itching on arms, ears, scalp,  stomach and legs. twitching under skin like a spasm.  Fatigue.  Stomach cramps.
Rash on insides of both elbows. Red and bumpy. Not itching or burning. Rashes reappear every so often since second dose.; This is a spontaneous report from a contactable consumer reported for a patient. A 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the anatomical location (arm left) on 19Feb2021 at 08:15 (at the age of 34-years-old), as a second single dose for COVID-19 Immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route on an unspecified date, as a first single dose for COVID-19 immunisation. On an unknown date, the patient experienced rash on insides of both elbows. Red and bumpy. Not itching or burning. Rashes reappear every so often since second dose. The patient did not receive any treatment for the reported events. The clinical outcome of rash is not recovered. No follow-up attempts are possible. No further information is expected.